Clinical Outcomes in Narcolepsy and Cataplexy: An Evaluation of Reboxetine Treatment (CONCERT)
Clinical trial NCT03881852 · COMPLETED
Trial details
- NCT number
- NCT03881852
- Sponsor
- Axsome Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-05
- Primary completion
- 2019-11-27
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.